Thiazolidinediones, including rosiglitazone and pioglitazone, are oral insulin‐sensitizing medications that have been widely used in the treatment of type 2 diabetes mellitus (T2DM).14 The gene discussed is INS; the disease is type 2 diabetes mellitus.